Income Statement
RANI THERAPEUTICS HOLDINGS, INC.
RANI
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
1.63 | 1.03 | - | 0.00 | 2.72 |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
1.63 | 1.03 | - | - | 2.72 |
|
Operating Expenses
|
39.94 | 54.34 | 66.10 | 63.45 | -54.32 |
|
Research & Development
|
20.21 | 26.68 | 39.62 | 36.61 | 26.48 |
|
Selling, General & Administrative
|
19.74 | 23.95 | 26.48 | 26.84 | 27.83 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-38.31 | -53.31 | -66.10 | -63.45 | 57.03 |
|
Non-Operating Income
|
- | - | 1.78 | -0.18 | 110.08 |
|
Interest Income
|
- | - | - | - | 0.09 |
|
Interest Expense
|
2.89 | 5.03 | 5.09 | 1.07 | 0.47 |
|
Other Non-Op Income / Expense
|
- | - | - | - | - |
|
Income Before Tax
|
- | - | -67.88 | -63.27 | -53.05 |
|
Income Tax Expense
|
- | - | -33.91 | -32.69 | -21.32 |
|
Non-Controlling Interest
|
-11.28 | -26.57 | -33.91 | -32.76 | -44.76 |
|
Net Income
|
-29.67 | -30.02 | -33.97 | -30.59 | -31.73 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-37.41 | -52.29 | -65.28 | -62.90 | 57.03 |
|
Earnings Per Share (Basic)
|
-0.45 | -1.05 | -1.33 | -1.28 | - |
|
Diluted EPS
|
-0.45 | -1.05 | -1.33 | -1.28 | - |
|
Weighted Average Shares
|
66.14 | 28.48 | 0.03 | 0.02 | - |
|
Diluted Weighted Avg Shares
|
66.14 | 28.48 | 0.03 | 0.02 | - |
|
Comprehensive Income
|
-29.68 | -30.00 | -33.91 | -30.66 | - |